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ABSTRACT MA/MyJ mice express a natural antibody to the highly oncogenic polyoma virus. C57BR/cdJ
mice lack this antibody but mount an adaptive T-cell response to the virus. Analysis of F2 progeny of a cross
between these strains reveals a pattern of inheritance of expression of the natural antibody involving two
genes in an epistatic relationship.
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Two forms of resistance in inbred strains of mice to the oncogenic
effects of polyoma virus emerged in the course of studies of the effects
of ionizing radiation on development of virus-induced tumors (Carroll
et al. 1999). C57BR/cdJ mice (BR) are resistant to tumor induction on
the basis of a well characterized cytolytic T-cell response targeting the
major virus transforming protein (Lukacher and Wilson 1998). This
adaptive immune response is readily overcome by an immunosup-
pressive dose of radiation (Carroll et al. 1999; Lukacher et al. 1995). In
contrast, MA/MyJ mice (MA) maintain their resistance to tumor in-
duction by the virus after irradiation. MA also manifest another un-
usual feature, which is resistance to infection by a highly virulent
strain of polyoma virus that rapidly kills newborn BR mice and mice
of other strains. This resistance is transmitted as a dominant or semi-
dominant trait (Carroll et al. 1999).
Sera from normal MA mice show high levels of a natural antibody
capable of neutralizing the virus. A hemagglutination-inhibition (HA-I)
assay (Carroll et al. 2007) based on serial twofold dilutions of sera
reveals the presence of this natural antibody. Titers are in the range
of 2560 to 5120 for MA, 40 to 80 for BR, and 320 to 640 for [MAxBR]
F1 animals. The neutralizing activity of sera from uninfected MA is
r o u g h l ya no r d e ro fm a g n i t u d el o w e rt h a nt h a tf o u n di ne x p e r i m e n t a l l y
or naturally infected mice (Carroll et al. 2007). It nevertheless accounts
in all likelihood for all or part of the unusual resistance of MA. Here, we
r e p o r tt h eu s eo fg e n o m e - w i d es i n g l en u c l e o t i d ep o l y m o r p h i s m( S N P )
analysis of the F2 progeny of a cross between MA and BR to identify
the genetic loci controlling production of the natural antibody.
MA and BR were crossed in both parental directions. F1 mice from
each pairing were used to generate a total of 192 F2 animals for
phenotyping (Figure 1). No difference based on parental pairings of
Figure 1 Results of a hemagglutination inhibition assay on F2 mice.
Serial twofold dilutions of sera from normal 4- to 5-week-old mice were
mixed with an equal volume of virus suspension and incubated at
room temperature for 45 min. An equal volume of guinea pig red
blood cell suspension was added, and cells were allowed to settle for 4
hours at 4C. HA-I titers are expressed as the greatest dilution of sera
that prevents agglutination of the red blood cells by the virus (Carroll
et al. 2007).
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Volume 2 | March 2012 | 353Figure 2 QTL mapping results. (A) DNAs from F2 high-titer and low-titer mice were genotyped by the Genetic Analysis Facility of the Center for Applied
Genomics at The Hospital for Sick Children in Toronto, Ontario, with use of the Illumina mouse MD linkage panel. F2 phenotypic and genotypic data (File
S1) were imported into along with the genotypic data into J/QTL (http://churchill.jax.org/software/jqtl.shtml), a graphical interface to R/QTL (Broman et al.
2003). QTL were identiﬁed and plotted with a binary phenotype model with the expectation maximization (EM) algorithm through the “Run One QTL
Genome Scan” function. The horizontal dotted line demarcates the genome-wide adjusted P ¼ 0.05 threshold estimated with 1,000,000 permutations
(Lystig 2003). All reported P values are genome-wide adjusted. (B) Genotype plots using the “Display Genotype Plot” function were generated around the
SNPs corresponding to the LOD peaks on chromosomes 4 and 7. Each column represents a mouse and each row a SNP. Red, homozygous MA alleles;
blue, homozygous BR alleles; green, heterozygous; black, missing allele calls. Asterisks denote the SNPs most strongly linked to the phenotype.
354 | E. Andrews et al.the F1s was apparent. HA-I titers fell almost exclusively into three
discrete ranges corresponding to those found for parental and F1
mice: 2560 to 5120, high titer (MA-like); 320 to 640, intermediate
(F1-like); and 40 to 80, low titer (BR-like). Adding the three outliers
with titers of 1280 and 10,240 to the high titer group produces a dis-
tribution of 50 low titer, 93 intermediate, and 49 high titer, which is
consistent with a monogenetic pattern of inheritance (x2 test of dif-
ference ¼ 0.1979, P ¼ 0.91).
To identify the genetic map position of the locus or loci controlling
antibody levels, DNAs from 30 high-titer and 30 low-titer F2 mice
were analyzed. A genome-wide SNP array was used with 1449 SNPs,
of which 686 were informative between MA and BR (Figure 2). Quan-
titative trait loci (QTL) analysis across the genome revealed two dom-
inant peaks (Figure 2A), one on chromosome 4 [logarithm of the odds
(LOD) 18.06, P , 0.00001] and the other on chromosome 7 (LOD
18.06, P , 0.00001). The next greatest peak, on chromosome 19 (LOD
3.12, P ¼ 0.219) fails to reach the threshold P of 0.05. These results
point clearly to the involvement of two genes underlying expression of
the virus-neutralizing antibody. Further clariﬁcation is gained from
examining allele distributions in the peak regions of chromosomes 4
and 7 marked ( )i nF i g u r e2 B .
All 30 of the high-titer F2 mice are homozygous for MA alleles
throughout the peak region of chromosome 7. These mice show
a roughly 1:2:1 segregation of genotypes (MA/MA: MA/BR: BR/
BR) in the peak region of chromosome 4. High-titer antibody in
these mice is therefore conferred by chromosome 7 independently
of the genotype on chromosome 4. Homozygosity of the MA allele
o nc h r o m o s o m e7t h u sa c t si na ne p i s t a t i cm a n n e rt ot h eg e n eo n
chromosome 4. Of the 30 low-titer F2 mice, all are homozygous for
the BR allele on chromosome 4. This homozygous condition is
necessary but not sufﬁcient for dictating low titers because none of
t h e s em i c ei sh o m o z y g o u sf o rM Aa l l e l e si nt h ep e a kr e g i o no f
chromosome 7. The ratio of MA/BR to BR/BR mice in the peak
region of chromosome 7 is roughly 2:1, reﬂecting the epistatic ef-
fect of the MA gene on chromosome 7 when present in a homo-
zygous condition.
The identities of the genes on chromosomes 4 and 7 and how they
may interact remain unknown. To deﬁne optimal regions on these
chromosomes in which to search for candidate genes, Bayesian 95%
credible intervals (Sen and Churchill 2001) were calculated. Based on
NCBI Build 37.1 of the mouse genome, the interval on chromosome 4
is 62.5 to 78.2 Mb and on chromosome 7 85.4 to 96.7 Mb. Interest-
ingly, several genes involved in innate immune responses reside in this
region of chromosome 7 (Yang et al. 2009). Genes involved in innate
immune responses to viruses, evolution of natural antibody, or IgM
rearrangement, as well as ones possibly linked to radiation resistance,
are among the logical ones to pursue.
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